Moody’s also assigned an “MIG 1” rating to PMC’s series 2016 bond anticipation notes and affirmed the “MIG 1” rating on PMC’s series 2015 bond anticipation notes.
The “A3” rating affirmation is based on several factors, including PMC’s leading market position, strong physician recruitment and affiliation with Mayo Clinic.
The outlook is stable, reflecting Moody’s expectations that PMC will continue improving financial results in fiscal year 2016 and fiscal year 2017.
More articles on healthcare finance:
5 latest revenue cycle company updates: Jan. 25
Standardized health plans could reduce out-of-pocket spending: 6 things to know
Healthcare outpaces Social Security spending for 1st time: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
